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In Brief
Brain orexin cells control arousal, but
pathological deregulation of their activity
can produce sleepiness, obesity, and
anxiety. Gonza´lez et al. show that the
voluntary act of eating can rapidly
downregulate orexin cell activity
irrespective of taste or calories, whereas
obesity resulting from orexin
underactivity can be reversed by a mild
diet.r Ltd.
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In humans and rodents, loss of brain orexin/hypo-
cretin (OH) neurons causes pathological sleepiness
[1–4], whereas OH hyperactivity is associated with
stress and anxiety [5–10]. OH cell control is thus
of considerable interest. OH cells are activated
by fasting [11, 12] and proposed to stimulate
eating [13]. However, OH cells are also activated
by diverse feeding-unrelated stressors [14–17]
and stimulate locomotion and ‘‘fight-or-flight’’ re-
sponses [18–20]. Such OH-mediated behaviors pre-
sumably preclude concurrent eating, and loss of OH
cells produces obesity, suggesting that OH cells
facilitate net energy expenditure rather than energy
intake [2, 21–23]. The relationship between OH cells
and eating, therefore, remains unclear. Here we
investigated this issue at the level of natural physio-
logical activity of OH cells. First, we monitored
eating-associated dynamics of OH cells using fiber
photometry in free-feeding mice. OH cell activity
decreased within milliseconds after eating onset,
and remained in a down state during eating. This
OH inactivation occurred with foods of diverse
tastes and textures, as well as with calorie-free
‘‘food,’’ in both fed and fasted mice, suggesting
that it is driven by the act of eating itself. Second,
we probed the implications of natural OH cell sig-
nals for eating and weight in a new conditional OH
cell-knockout model. Complete OH cell inactivation
in adult brain induced a hitherto unrecognized over-
eating phenotype and caused overweight that was
preventable by mild dieting. These results support
an inhibitory interplay between OH signals and
eating, and demonstrate that OH cell activity is
rapidly controllable, across nutritional states, by
voluntary action.2486 Current Biology 26, 2486–2491, September 26, 2016 ª 2016 Th
This is an open access article under the CC BY license (http://creativeRESULTS AND DISCUSSION
Natural Population Dynamics of OH Cells during
Voluntary Eating
Orexin/hypocretin (OH) cells are activated by fasting and low
glucose levels, and have been hypothesized to drive eating until
ingested glucose slowly (within minutes) inactivates them (Fig-
ure 1A) [19, 24].WemeasuredOH cell population activity in freely
behaving mice using fiber photometry [17] of the GCaMP6s ac-
tivity indicator targeted to OH cells while monitoring eating using
video tracking or touch sensors (Figure 1B; Figures S1–S3). In
freely behaving mice, we observed activity fluctuations in OH-
GCaMP6s, but not in OH-eGFP, cells (Figure 1C). Themagnitude
of these fluctuations (10%–40% DF/F) was similar to network
dynamics recorded with similar methods in other brain regions
[25, 26]. Our experimental quantification of photometry perfor-
mance suggested that >95% of the fluorescence signal would
come from 0.5 mm from the fiber tip (Figures S2A and S2B),
which is well suited to OH cluster dimensions in themouse hypo-
thalamus. We confirmed that the GCaMP6s signal reflects phys-
iological OH cell modulation by reproducing the previously
described in vivo activation of OH cells by sounds [14] and
in vitro inhibition of OH cells by glucose [24] (Figures S1C and
S1D). The OH-GCaMP6s signal was directly proportional to the
OH cell firing rate (Figure S3).
We found that food contact depressed OH cell activity
extremely rapidly (<1 s of food contact) (Figures 1D–1H). OH
cells returned to an up state within seconds after food contact
was stopped (Figures 1D–1F; Figure S2E), suggesting that the
rapid OH cell modulation is not caused by slowly varying nutri-
tional signals. This effect was seen in both fasted and fed OH-
GCaMP6s mice, but not in the OH-eGFP controls (Figure 1H).
For liquid foods, the fall in OH cell activity was apparent within
just a few licks (Figure 1F; Figures S2E and S2F). The eating-
associated OH cell depression was similar for foods of differing
consistency (e.g., chow versus yogurt) and different appetitive
value (e.g., chow versus peanut butter) (Figure 1H). To confirm
whether caloric content had a role, we tested a zero-calorie
‘‘food’’ (sucralose solution), and still observed robust OH cell
inactivation during licking (Figure 1H). Overall, these data showe Author(s). Published by Elsevier Ltd.
commons.org/licenses/by/4.0/).
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B Figure 1. Impact of Eating on Natural OH
Cell Dynamics In Vivo
(A) A hypothesis for temporal modulation of OH
cells during eating.
(B) Left: targeting scheme of GCaMP6s to OH cells
for obtaining the data shown in this figure (data
using alternative targeting of OH cells are shown in
Figures S2C–S2F). Right: localization of injection
site and path of the optical fiber. 3V, third ventricle;
L, D, M, V, lateral, dorsal, medial, ventral; VMH,
ventromedial hypothalamus; Arc, arcuate nucleus.
Representative image of n = 5 brains.
(C) Left: recording scheme. Right: fluorescence
trace during cage exploration for mice expressing
GCaMP6s or eGFP in OH neurons. Typical exam-
ples of n = 5 and n = 3 mice, respectively.
(D) Fluorescence trace during introduction of food
into the cage and its subsequent consumption
(orange-shaded area). Food was a drop of straw-
berry milkshake. Typical example of n = 5 mice.
(E) Left: fluorescence trace during repeated bouts
of food contact (orange-shaded areas; food is
strawberry milkshake). Typical example of n = 5
mice. Right: quantification of fluorescence change
during the first 2 s of consecutive food-contact
bouts (means ± SEM, n = 3 mice).
(F) Fluorescence change during food licking de-
tected with a touch sensor (food is strawberry
milkshake). Typical example of n = 5 mice across
eight foods shown in (H), right.
(G) Top: probability density of OH cell activity.
Bottom: distribution of the bootstrap differences of
the same data. Typical example of n = 3 mice.
(H) Left: peri-event plots aligned to the onset of
licking bouts (dashed line). The heatmap shows
individual bouts (two per mouse), and the trace
below the heatmap shows the mean of trial aver-
ages from each mouse (red line; gray lines repre-
sent SEM); n = 5 mice. Right: quantification of the
experiment shown on the left, for different foods.
Each column shows fluorescence change during
the first 4 s of a licking bout (mean signals during
3.5 to 4 s minus signal during 0.5 to 0 s, times
relative to the first lick). Data are means ± SEM of
n = 4 mice in each group. Left column is control
(OH-eGFPmice); other columns are OH-GCaMP6s
mice; for food abbreviations, see the Supplemental
Experimental Procedures; fast, overnight fasted
before the experiment; fed, ad libitum feeding
before the experiment. All changes in OH-
GCaMP6s mice were significant (p < 0.05 in
one-sample t tests of response to each food,
DF = 3, t > 3.4).
See also Figures S1–S3 and Movie S1.that OH cells are rapidly inactivated by the act of eating, irre-
spective of food properties or body energy state.
Natural Impact of OH Neurons on Eating
The above correlative data have two possible causal interpreta-
tions: (1) OH cells oppose eating, and are disabled to enable
eating, or (2) OH cells drive eating, and so eating stops shortly af-
ter OH cells are silenced. To distinguish between these possibil-
ities, we investigated causality between natural OH activity and
eating by inactivating OH cells in adult mice through a toxin
receptor-mediated cell-knockout strategy [27, 28].We generated new transgenic mice in which the expression of
the human diphtheria toxin receptor (DTR) is driven by the OH
promoter (see the Supplemental Experimental Procedures). In
OH-DTR mice, but not in control WT mice, the injection of diph-
theria toxin ablated all OH cells, but not the neighboring melanin-
concentrating hormone-containing cells, within a couple of days
(Figures 2A–2D). This complete inactivation of OH cells, which is
not as readily achievable through alternative silencing methods
such as opto- and chemo-genetics, may be critical for elucida-
tion of their full impact, because key deficiency phenotypes are
not apparent upon partial inactivation [13].Current Biology 26, 2486–2491, September 26, 2016 2487
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Figure 2. Impact of Natural OH Cell Activity on Spontaneous Feeding Rhythm
(A) Strategy for destroying OH neurons in adult mice.
(B) Immunostaining for OH (green) andmelanin-concentrating hormone-containing (MCH) (red) neurons in DTR (top) and DTR+ (bottom) littermates 10 days after
DT injection. The DT injection led to the loss of OH neurons in all brains tested (n = 8). Scale bars represent 500 mm (left) and 100 mm (right). Dashed boxes in the
left-hand panels indicate the areas shown in corresponding right-hand panels.
(C) Time course of OH cell loss after DT injection in DTR+ and their DTR littermates (n = 5 mice in each group).
(D) Quantification of OH cell number >21 days after DT injection in DTR and DTR+ littermates. Unpaired t test, t(13.3) = 16.41, p = 3.2e-10, n = 8 mice in each
group.
(E) Body weight time series of DTR and DTR+ littermates after DT injection. ANCOVA, F(1, 12) = 12.07, p = 0.005, n = 7 mice in each group.
(F) Daily rhythm of eating in DTR and DTR+ mice after DT injection, across days. n = 7 mice in each group.
(G)Mean daily rhythm of eating (average of 14 days; gray box is lights off) in DT-injected DTR and DTR+mice. Repeated-measures ANOVA, interaction: F(7, 84) =
2.38, p = 0.029. Significant differences were found only at the time of day indicated (***p < 0.001, Holm correction for multiple comparisons). n = 7 mice in each
group.
(H) Total food consumed after DT injection, relative to the time of day. Repeated-measures ANOVA, interaction: F(7, 84) = 3.07, p = 0.006. Pairwise comparisons
revealed statistical differences at the time of day indicated (***p < 0.001, Holm correction for multiple comparisons). n = 7 animals in each group.
See also Figure S4.DT injection led to greater weight gain in DTR+ mice than in
their DTR littermates (Figure 2E), confirming that OH cells
oppose overweight. Next, we probed food intake patterns at
an hourly temporal resolution, using a food hopper specifically
designed to re-capture any food spillage and a food-weighing
system whose errors were sufficiently low to report changes
greater than 0.01 g (Figures S4A–S4D). In DTR mice injected2488 Current Biology 26, 2486–2491, September 26, 2016with DT (control mice) this revealed a robust daily eating
rhythm, where food intake was largely restricted to the lights-
off phase (‘‘night’’) but had a pronounced ‘‘dip’’ late at night
(Figures 2F and 2G). However, in DTR+ mice injected with
DT, this dip in eating was significantly reduced, causing them
to consume significantly more food during the late night (Fig-
ures 2F–2H; note that the magnitude of this overeating is well
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Figure 3. Impact of Natural OH Cell Activity
on Rebound Eating after Fasting
(A) Eating responses to a 1-day fast in control mice
(OH+, DTR mice injected with DT) and their OH
cell-deficient littermates (OH, DTR+mice injected
with DT). n = 6 mice in each group.
(B) Daily eating rhythms before and after a 1-day
fast in OH+ and OH littermates. n = 6mice in each
group.
(C) Daily eating rhythms 3 days before and after
food restriction. Repeated-measures ANOVA,
interaction: F(7, 35) = 3.36, p = 0.008 (left) and
F(7, 35) = 3.53, p = 0.006 (right). Follow-up tests
showed significant differences only at times
marked with asterisks (**p < 0.01, ***p < 0.001,
Holm correction for multiple comparisons). n = 6
mice in each group.
(D) Total food consumed 3 days before (fed) and
3 days after (fast) food restriction in OH+ and OH
mice (n = 6 in each group) during early night (ZT12–
14) compared to that consumed during late night
(ZT18–20). Paired t tests.above the sensitivity limit of the food-weight detector; Figures
S4A–S4D). Interestingly, this overeating did not cause compen-
satory undereating at other times of day (Figures 2F–2H).
Glucose tolerance in OH cell-deficient mice was normal (Fig-
ure S4E), as previously observed for OH-deficient humans
[29], suggesting that OH cell loss does not prevent glucose up-
take from blood into tissues. Overall, these data show that the
natural OH cell activity prevents overeating and suppresses
weight gain.
Temporal Dissociation of Fasting-Dependent and OH-
Dependent Eating
The above findings demonstrate that the natural activity of
OH cells opposes eating, and therefore challenge current
models postulating that OH cells stimulate eating. However,
because OH cells are activated by fasting, it is still possible
that they become critical for compensatory eating after fast-Current Biologying [11]. To examine this possibility,
we measured rebound overeating after
fasting in OH mice (i.e., DTR+ mice
injected with DT), but surprisingly
found it similar to their OH+ littermates
(DTR mice injected with DT) (Fig-
ures 3A and 3B). Furthermore, although
both the OH and OH+ mice overate
for several days after fasting, on each
of these days they ate more only in
the early-night phase (Figures 3C and
3D), i.e., a different phase from that
when food intake was naturally regu-
lated by OH cells (Figure 2G). This
temporal dissociation reveals that, at
least under the conditions studied
here, nutrient shortage and OH cells
regulate distinct daily phases of food
intake. These data suggest that OH
cells are not required for compensa-tory overeating after fasting, at least when food is readily
available.
Normalizing Eating Prevents Weight Gain in OH Cell-
Deficient Mice
Identifying an effective strategy for body weight control in OH-
deficient individuals is of clinical interest [21, 30]. In our experi-
ments, the overeating in the OH mice (10 g of food over
50 days or 2% daily) could be theoretically sufficient to
account for the overweight in these mice based on the following
reasoning. The OH mice gain 10% weight (relative to OH+
controls) over about 45 days, i.e., 0.2% daily excess weight
gain (Figure 2E). Our fasting experiment shows that, in 1 day, a
100% change in food intake can cause a 10% change in weight
(Figure 3A). If this 10:1 relation holds in general, then the 2%
daily eating increase would be sufficient to account for the
0.2% daily excess weight gain.26, 2486–2491, September 26, 2016 2489
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Figure 4. Prevention of Weight Gain Caused by OH Cell Loss by
Dieting
(A) Strategy for pair-feeding experiment (OH+, DTR mice injected with DT;
OH, their DTR+ littermates injected with DT).
(B) Weight gain of OH and OH+ littermates during weeks 2 and 3 after
DT injection, and during free feeding (unpaired t test, t(11.93) = 4.327,
p = 0.0009, n = 7 mice in each group) and pair feeding (unpaired t test,
t(5.41) = 0.598, p = 0.574, n = 4 animals in each group).Therefore, we investigated whether the excess weight gain in
the OH mice can be controlled by mild dietary restriction. To
achieve this, we employed the pair-feeding paradigm [31], where
the food available to each OHmouse wasmatched daily to that
eaten by its OH+ littermate control (Figure 4A). This effectively
fixes food intake, but in a mild physiological manner without
abnormal periods of fasting [31].
Pair feeding the OH mice prevented them from becoming
heavier than their OH+ siblings (Figure 4B). In contrast, in control
experiments performed during the same time, free-feeding OH
mice became significantly heavier than their OH+ siblings (Fig-
ure 4B). Note that this does not exclude that factors other than
eating may mediate weight gain of OHmice, for example, alter-
ations in sleep/wake rhythms and energy expenditure [2, 31, 32].
However, our results do suggest that, in the absence of over-
eating, such factors are insufficient to cause the excessive
weight gain.
Conclusions
Our findings reveal population activity dynamics of OH cells dur-
ing eating, and suggest that eating is less likely to occur when
OH cells are naturally active. OH cells stimulate ‘‘non-eating’’ be-
haviors such as locomotion [18]. Although these behaviors
expend energy, it is difficult to eat while performing them.
Thus, a possible evolutionary rationale for our findings is2490 Current Biology 26, 2486–2491, September 26, 2016that suppression of OH-dependent non-eating behaviors—by
silencing OH cells upon food contact—would facilitate eating
(e.g., by making the mouse less likely to move away from the
food). It is tempting to speculate that increased eating after
experimental stimulation of theOH system [11, 13] may be a sec-
ondary response to OH-driven energy expenditure [33], rather
than a primary function of OH cells.
Our findings identify interesting directions for future work.
We found that the weight gain in OH-cell-deficient mice could
be prevented by mild caloric restriction. This suggests
that development of non-pharmacological interventions may
be useful in managing excessive weight gain in neuropsy-
chiatric conditions associated with reduced OH signaling
[3, 21, 30, 34]. Furthermore, our results suggest that OH
cells—whose hyperactivity has been implicated in patholog-
ical states such as panic anxiety [5]—could be inhibited by
simple voluntary actions such as eating, irrespective of the na-
ture of the food. Further research into neuroscience-based
lifestyle interventions for anxiety and obesity might lead to
treatments that are easier to implement and have fewer side
effects.
EXPERIMENTAL PROCEDURES
OH cell activity was recorded in vivo using fiber photometry of the GCaMP6s
activity indicator targeted to OH cells either using previously characterized
orexin-Cre mice and Cre-inducible GCaMP6s viral vectors [35, 36] (Figure 1;
Figure S1B) or using a newly generated orexin promoter-dependent adeno-
associated virus (AAV)-GCaMP6s vector (characterized in Figures S2C–S2F
and described in the Supplemental Experimental Procedures). OH cells were
specifically and completely inactivated using a diphtheria toxin receptor-medi-
ated cell-ablation strategy in newly generated OH-DTR transgenic mice
described in the Supplemental Experimental Procedures. Food intake was
monitored using a TSE PhenoMaster system, whose sensitivity and accuracy
were directly determined in our laboratory (Figures S4A–S4D). Immunohisto-
chemistry and glucose tolerance tests were performed using standard tech-
niques (see the Supplemental Experimental Procedures).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one movie and can be found with this article online at
http://dx.doi.org/10.1016/j.cub.2016.07.013.
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